8-K from Portola Pharma Shows Co. Entered Commercial Supply Deal with CMC ICOS Biologics on Jul. 1st, Co. Will Make Immediate Upfront Payment of $10M, to Make Reservation Payment of $4.6M in Nov.
Paul Quintaro